Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study

NCT00736255 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder
Nicotine Dependence

Interventions

DRUG: Transdermal Nicotine Patch
DRUG: Lis-dexamphetamine (Vyvanse)
DRUG: Placebo

Sponsor

Duke University

Collaborators

[object Object]